Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 536/24.5
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > Nitrogen containing > N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) > Dna or rna fragments or modified forms thereof (e.g., genes, etc.) > Nucleic acid expression inhibitors
Description: Fragments of DNA or RNA which are effective inhibitors of transcription or translation.


Patents under this class:

Patent Number Title Of Patent Date Issued
7405292 Cellular genes regulated by HIV-1 infection and methods of use thereof Jul. 29, 2008
7405285 Immunostimulatory oligonucleotide multimers Jul. 29, 2008
7405205 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase Jul. 29, 2008
7404969 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules Jul. 29, 2008
7402574 Antisense composition and method for treating cancer Jul. 22, 2008
7399853 Modulation of glucagon receptor expression Jul. 15, 2008
7399586 Modulation of biological signal transduction by RNA interference Jul. 15, 2008
7396922 Regulation of hypoxia-inducible gene expression with antisense Inhibitory PAS domain protein Jul. 8, 2008
7393951 Antisense oligonucleotide having anticancerous activity Jul. 1, 2008
7393950 Antisense oligonucleotides targeted to human CDC45 Jul. 1, 2008
7393949 Human immunodeficiency virus (HIV) nucleotide sequences Jul. 1, 2008
7390792 MicroRNA1 therapies Jun. 24, 2008
7381819 Composition for treatment or prevention of endometrial cancer and method of preventing or treating endometrial cancer using the composition Jun. 3, 2008
7381708 Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye Jun. 3, 2008
7378275 Canine IL-13 receptor alpha-1 subunit nucleic acid molecules May. 27, 2008
7378243 Nucleic acid cloning May. 27, 2008
7375212 Modulation of Aurora B expression May. 20, 2008
7371850 Method and composition for reducing expression of ROCK-II May. 13, 2008
7371735 Inhibitor oligonucleotides and their use for specific repression of a gene May. 13, 2008
7368561 Isolation of antisense oligonucleotides May. 6, 2008
7368559 Fc.gamma.RIIA-specific nucleic acid interference May. 6, 2008
7368436 TRPM-2 antisense therapy May. 6, 2008
7365058 MicroRNA and methods for inhibiting same Apr. 29, 2008
7361752 RNAi modulation of MLL-AF4 and uses thereof Apr. 22, 2008
7358418 Isoforms of eIF-5A: senescence-induced eLF5A; wounding-induced eIF-4A; growth eIF-5A; and DHS Apr. 15, 2008
7358223 Biodegradable cationic polymers Apr. 15, 2008
7355056 Transfection agents Apr. 8, 2008
7355035 Catalytic molecules Apr. 8, 2008
7351535 Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter protein ABC1 Apr. 1, 2008
7351532 DNA sequence analysis Apr. 1, 2008
7349808 System and method for tracking and controlling infections Mar. 25, 2008
7348314 Compositions and methods for inhibiting viral replication Mar. 25, 2008
7345027 Compositions and methods for siRNA inhibition of angiogenesis Mar. 18, 2008
7345025 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells Mar. 18, 2008
7342111 Adeno-associated virus-delivered ribozyme compositions and methods of use Mar. 11, 2008
7339051 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) Mar. 4, 2008
7335764 Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression Feb. 26, 2008
7335763 Herpesvirus ribozymes and vectors Feb. 26, 2008
7335750 Hybrid compositions for intracellular targeting Feb. 26, 2008
7332335 Decreasing cell proliferation by decreasing levels of PP5 Feb. 19, 2008
7329741 Polynucleotides that hybridize to DP-75 and their use Feb. 12, 2008
7329649 Combinatorial methods for inducing cancer cell death Feb. 12, 2008
7326783 Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms Feb. 5, 2008
7323560 Plastidic phosphoglucomutase genes Jan. 29, 2008
7323319 RNA containing coenzymes, biotin, or fluorophores, and methods for their preparation and use Jan. 29, 2008
7320965 Compositions and methods for inhibiting expression of Huntingtin gene Jan. 22, 2008
7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof Jan. 15, 2008
7314927 Regulation of bcl-2 gene expression Jan. 1, 2008
7312325 RNA aptamers and methods for identifying the same Dec. 25, 2007
7309786 Oligonucleotide antagonist for human tumor necrosis factor .alpha. (TNF-.alpha.) Dec. 18, 2007



 
 
  Recently Added Patents
Heat exchanger
Liquid crystal display device and electronic apparatus
Memory device with speculative commands to memory core
Electronic book
Column path circuit
Variable formatting of cells
Beverage can
  Randomly Featured Patents
Clamp assembly and method
Method for locating an on-bottom seismic cable
Sealing apparatus and sealing method using the sealing apparatus
Carbon-porous media composite electrode and preparation method thereof
Tape drive
Telescoping implement attachment for a motor vehicle
Jack apparatus
Heat stable laked monoazo pigment compositions
Digital computer system using embedded comments to manipulate virtual controller functions
Device for the metallic sealing of an intermediate partition on a vessel